Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease

Journal of Viral Hepatitis

Volumn 22, Issue 7, 2015, Pages 574-580

  Cholongitas, E ^a   Vasiliadis, T ^b   Goulis, I ^a   Fouzas, I ^b   Antoniadis, N ^b   Papanikolaou, V ^b   Akriviadis, E ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

glomerular filtration rate; kidney; liver transplantation; renal function; telbivudine

Indexed keywords

CALCINEURIN INHIBITOR; TELBIVUDINE; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; THYMIDINE; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECIPIENT; RISK ASSESSMENT; RISK FACTOR; VIRUS IDENTIFICATION; YOUNG ADULT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BLOOD; CHEMOPROPHYLAXIS; COMPLICATION; DRUG EFFECTS; HEPATITIS B, CHRONIC; KIDNEY; KIDNEY FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY;

ADULT; AGED; ANTIVIRAL AGENTS; CHEMOPREVENTION; DNA, VIRAL; FEMALE; GLOMERULAR FILTRATION RATE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THYMIDINE; YOUNG ADULT;

EID: 84930327804     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12362     Document Type: Article

References (17)

1. Cholongitas E, Goulis J, Akriviadis E, Papatheodoridis GV,. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review. Liver Transpl 2011; 17: 1176-1190.
2. Papatheodoridis GV, Cholongitas E, Archimandritis AJ, Burroughs AK,. Current management of hepatitis B virus infection before and after liver transplantation. Liver Int 2009; 29: 1294-1305.
3. Cholongitas E, Papatheodoridis GV,. Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation. World J Gastroenterol 2013; 19: 9189-9197.
4. Cholongitas E, Papatheodoridis GV,. High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. Am J Transplant 2013; 13: 353-362.
5. Pipili CL, Papatheodoridis GV, Cholongitas EC,. Treatment of hepatitis B in patients with chronic kidney disease. Kidney Int 2013; 84 (5): 880-5.
6. Pipili C, Cholongitas E, Papatheodoridis G,. Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease. Aliment Pharmacol Ther 2014; 39: 35-46.
7. Wang Y, Thongsawat S, Gane EJ, et al,. Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B. J Viral Hepat 2013; 20: e37-e46.
8. Gane EJ, Deray G, Liaw YF, et al,. Telbivudine improves renal function in patients with chronic hepatitis B. Gastroenterology 2014; 146: 138-146.
9. Yapali S, Lok AS,. Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects. Gastroenterology 2014; 146: 15-19.
10. De Simone P, Nevens F, De CL, et al,. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant 2012; 12: 3008-3020.
11. Ojo AO, Held PJ, Port FK, et al,. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
13. Levey AS, Stevens LA, Schmid CH, et al,. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
14. Vivarelli M, Cucchetti A, Piscaglia F, et al,. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 2005; 11: 497-503.
15. Gonwa TA,. Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transpl 2001; 7: S22-S26.
16. Perrella A, Lanza AG, Santaniello W, et al,. Telbivudin as prophylaxis for hepatitis B virus recurrence after liver transplantation: a case series in single-center experience. Transplant Proc 2012; 44: 1986-1988.
17. Karasu Z, Turan I, Duman S, et al,. Telbivudin: more caution is needed in liver transplant recipients. J Hepatol 2014; 60 (Suppl 1): S384.